{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:32:38Z","timestamp":1793046758744,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T00:00:00Z","timestamp":1315872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T00:00:00Z","timestamp":1315872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/tpj.2011.41","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T10:23:21Z","timestamp":1315909401000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["A whole-genome association study of major determinants for allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese patients"],"prefix":"10.1038","volume":"13","author":[{"given":"M","family":"Tohkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kaniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Ikezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Japan Pharmacogenomics Data Science Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,13]]},"reference":[{"key":"BFtpj201141_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00002281-200205000-00015","volume":"14","author":"RL Wortmann","year":"2002","unstructured":"Wortmann RL . Gout and hyperuricemia. Curr Opin Rheumatol 2002; 14: 281\u2013286.","journal-title":"Curr Opin Rheumatol"},{"key":"BFtpj201141_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","volume":"7","author":"WH Chung","year":"2007","unstructured":"Chung WH, Hung SI, Chen YT . Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007; 7: 317\u2013323.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"BFtpj201141_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2133\/dmpk.25.122","volume":"25","author":"M Tohkin","year":"2010","unstructured":"Tohkin M, Ishiguro A, Kaniwa N, Saito Y, Kurose K, Hasegawa R . Prediction of severe adverse drug reactions using pharmacogenetic biomarkers. Drug Metab Pharmacokinet 2010; 25: 122\u2013133.","journal-title":"Drug Metab Pharmacokinet"},{"key":"BFtpj201141_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC . Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92\u201396.","journal-title":"Arch Dermatol"},{"key":"BFtpj201141_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2332\/allergolint.55.9","volume":"55","author":"LE French","year":"2006","unstructured":"French LE . Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 2006; 55: 9\u201316.","journal-title":"Allergol Int"},{"key":"BFtpj201141_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2217\/pgs.09.11","volume":"10","author":"C Bowman","year":"2009","unstructured":"Bowman C, Delrieu O . Immunogenetics of drug-induced skin blistering disorders. Part I: perspective. Pharmacogenomics 2009; 10: 601\u2013621.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201141_CR7","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134\u20134139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201141_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","volume":"19","author":"W Tassaneeyakul","year":"2009","unstructured":"Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U et al. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 2009; 19: 704\u2013709.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201141_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18: 99\u2013107.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201141_CR10","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","volume":"9","author":"N Kaniwa","year":"2008","unstructured":"Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008; 9: 1617\u20131622.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201141_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd2423","volume":"6","author":"RA Wilke","year":"2007","unstructured":"Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, Zineh I et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 2007; 6: 904\u2013916.","journal-title":"Nat Rev Drug Discov"},{"key":"BFtpj201141_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1056\/NEJMe0805136","volume":"359","author":"Y Nakamura","year":"2008","unstructured":"Nakamura Y . Pharmacogenomics and drug toxicity. N Engl J Med 2008; 359: 856\u2013858.","journal-title":"N Engl J Med"},{"key":"BFtpj201141_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0029-1240009","volume":"29","author":"AK Daly","year":"2009","unstructured":"Daly AK, Day CP . Genetic association studies in drug-induced liver injury. Semin Liver Dis 2009; 29: 400\u2013411.","journal-title":"Semin Liver Dis"},{"key":"BFtpj201141_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559\u2013575.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201141_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000022901","volume":"50","author":"JH Zhao","year":"2000","unstructured":"Zhao JH, Curtis D, Sham PC . Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133\u2013139.","journal-title":"Hum Hered"},{"key":"BFtpj201141_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/bioinformatics\/bth071","volume":"20","author":"JH Zhao","year":"2004","unstructured":"Zhao JH . 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004; 20: 1325\u20131326.","journal-title":"Bioinformatics"},{"key":"BFtpj201141_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1034\/j.1600-0625.2003.00048.x","volume":"12","author":"SJ Holm","year":"2003","unstructured":"Holm SJ, Carlen LM, Mallbris L, Stahle-Backdahl M, O\u2019Brien KP . Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp Dermatol 2003; 12: 435\u2013444.","journal-title":"Exp Dermatol"},{"key":"BFtpj201141_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/ard.2004.031765","volume":"64","author":"P Rahman","year":"2005","unstructured":"Rahman P, Butt C, Siannis F, Farewell VT, Peddle L, Pellett FJ et al. Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations. Ann Rheum Dis 2005; 64: 1370\u20131372.","journal-title":"Ann Rheum Dis"},{"key":"BFtpj201141_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1046\/j.1523-1747.2002.19612.x","volume":"119","author":"XJ Zhang","year":"2002","unstructured":"Zhang XJ, He PP, Wang ZX, Zhang J, Li YB, Wang HY et al. Evidence for a major psoriasis susceptibility locus at 6p21(PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese hans. J Invest Dermatol 2002; 119: 1361\u20131366.","journal-title":"J Invest Dermatol"},{"key":"BFtpj201141_CR20","doi-asserted-by":"publisher","first-page":"e6030","DOI":"10.1371\/journal.pone.0006030","volume":"4","author":"S Suomela","year":"2009","unstructured":"Suomela S, Elomaa O, Skoog T, Ala-aho R, Jeskanen L, Parssinen J et al. CCHCR1 is up-regulated in skin cancer and associated with EGFR expression. PLoS One 2009; 4: e6030.","journal-title":"PLoS One"},{"key":"BFtpj201141_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/hmg\/ddm377","volume":"17","author":"I Tiala","year":"2008","unstructured":"Tiala I, Wakkinen J, Suomela S, Puolakkainen P, Tammi R, Forsberg S et al. The PSORS1 locus gene CCHCR1 affects keratinocyte proliferation in transgenic mice. Hum Mol Genet 2008; 17: 1043\u20131051.","journal-title":"Hum Mol Genet"},{"key":"BFtpj201141_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2340\/00015555-0184","volume":"87","author":"S Suomela","year":"2007","unstructured":"Suomela S, Kainu K, Onkamo P, Tiala I, Himberg J, Koskinen L et al. Clinical associations of the risk alleles of HLA-Cw6 and CCHCR1*WWCC in psoriasis. Acta Derm Venereol 2007; 87: 127\u2013134.","journal-title":"Acta Derm Venereol"},{"key":"BFtpj201141_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00109-006-0155-0","volume":"85","author":"I Tiala","year":"2007","unstructured":"Tiala I, Suomela S, Huuhtanen J, Wakkinen J, Holtta-Vuori M, Kainu K et al. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes. J Mol Med 2007; 85: 589\u2013601.","journal-title":"J Mol Med"},{"key":"BFtpj201141_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1517\/phgs.5.2.203.27481","volume":"5","author":"AR Hughes","year":"2004","unstructured":"Hughes AR, Mosteller M, Bansal AT, Davies K, Haneline SA, Lai EH et al. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 2004; 5: 203\u2013211.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201141_CR25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/591184","volume":"198","author":"S Colombo","year":"2008","unstructured":"Colombo S, Rauch A, Rotger M, Fellay J, Martinez R, Fux C et al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. J Infect Dis 2008; 198: 864\u2013867.","journal-title":"J Infect Dis"},{"key":"BFtpj201141_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358: 568\u2013579.","journal-title":"N Engl J Med"},{"key":"BFtpj201141_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1034\/j.1399-0039.2000.550303.x","volume":"55","author":"Y Teraoka","year":"2000","unstructured":"Teraoka Y, Naruse TK, Oka A, Matsuzawa Y, Shiina T, Iizuka M et al. Genetic polymorphisms in the cell growth regulated gene, SC1 telomeric of the HLA-C gene and lack of association of psoriasis vulgaris. Tissue Antigens 2000; 55: 206\u2013211.","journal-title":"Tissue Antigens"},{"key":"BFtpj201141_CR28","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1073\/pnas.050567397","volume":"97","author":"SA Migueles","year":"2000","unstructured":"Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97: 2709\u20132714.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201141_CR29","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1097\/00002030-200312050-00005","volume":"17","author":"M Altfeld","year":"2003","unstructured":"Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003; 17: 2581\u20132591.","journal-title":"AIDS"},{"key":"BFtpj201141_CR30","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.1143767","volume":"317","author":"J Fellay","year":"2007","unstructured":"Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317: 944\u2013947.","journal-title":"Science"},{"key":"BFtpj201141_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe\u2019er I, Floratos A et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41: 816\u2013819.","journal-title":"Nat Genet"},{"key":"BFtpj201141_CR32","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/hmg\/8.12.2165","volume":"8","author":"A Oka","year":"1999","unstructured":"Oka A, Tamiya G, Tomizawa M, Ota M, Katsuyama Y, Makino S et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111\u2009kb segment telomeric to the HLA-C gene. Hum Mol Genet 1999; 8: 2165\u20132170.","journal-title":"Hum Mol Genet"},{"key":"BFtpj201141_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.01.003","volume":"46","author":"YT Chang","year":"2007","unstructured":"Chang YT, Hsu CY, Chou CT, Lin MW, Shiao YM, Tsai CY et al. The genetic polymorphisms of POU5F1 gene are associated with psoriasis vulgaris in Chinese. J Dermatol Sci 2007; 46: 153\u2013156.","journal-title":"J Dermatol Sci"},{"key":"BFtpj201141_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/346067","volume":"72","author":"K Okamoto","year":"2003","unstructured":"Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 2003; 72: 303\u2013312.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201141_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/art.20043","volume":"50","author":"R Kilding","year":"2004","unstructured":"Kilding R, Iles MM, Timms JM, Worthington J, Wilson AG . Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus. Arthritis Rheum 2004; 50: 763\u2013769.","journal-title":"Arthritis Rheum"},{"key":"BFtpj201141_CR36","first-page":"741","volume":"35","author":"A Quinones-Lombrana","year":"2008","unstructured":"Quinones-Lombrana A, Lopez-Soto A, Ballina-Garcia FJ, Alperi-Lopez M, Queiro-Silva R, Lopez-Vazquez A et al. BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility. J Rheumatol 2008; 35: 741\u2013744.","journal-title":"J Rheumatol"},{"key":"BFtpj201141_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/QAD.0b013e32831db247","volume":"23","author":"D van Manen","year":"2009","unstructured":"van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van\u2019t Wout AB, Schuitemaker H . Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 2009; 23: 19\u201328.","journal-title":"AIDS"},{"key":"BFtpj201141_CR38","doi-asserted-by":"publisher","first-page":"e3636","DOI":"10.1371\/journal.pone.0003636","volume":"3","author":"G Catano","year":"2008","unstructured":"Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS One 2008; 3: e3636.","journal-title":"PLoS One"},{"key":"BFtpj201141_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/QAD.0b013e3282f470e4","volume":"22","author":"Y Han","year":"2008","unstructured":"Han Y, Lai J, Barditch-Crovo P, Gallant JE, Williams TM, Siliciano RF et al. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. AIDS 2008; 22: 541\u2013544.","journal-title":"AIDS"},{"key":"BFtpj201141_CR40","first-page":"139","volume":"9","author":"H Tanaka","year":"1996","unstructured":"Tanaka H, Akaza T, Juji T . Report of the Japanese Central Bone Marrow Data Center. Clin Transpl 1996; 9: 139\u2013144.","journal-title":"Clin Transpl"},{"key":"BFtpj201141_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s002510050262","volume":"46","author":"K Tokunaga","year":"1997","unstructured":"Tokunaga K, Ishikawa Y, Ogawa A, Wang H, Mitsunaga S, Moriyama S et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997; 46: 199\u2013205.","journal-title":"Immunogenetics"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201141","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:34:43Z","timestamp":1647945283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFtpj201141"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2011.41","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,13]]},"assertion":[{"value":"12 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest except one member of JPDSC, Mitsubishi Tanabe Pharma, which is a distributor of allopurinol in Japan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}